Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease; Prodromal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06869135
What this trial is testing

Saliva and Extracellular Vesicles for Neurodegenerative Diseases

Who this might be right for
Neurodegenerative DiseasesParkinson DiseaseAlzheimer Disease+3 more
Fondazione Don Carlo Gnocchi ETS 242
Not applicableStudy completedNCT04029623
What this trial is testing

Partnered Rhythmic Rehabilitation in Prodromal Alzheimer's Disease

Who this might be right for
Prodromal Alzheimer's Disease
Emory University 76
Not applicableEnded earlyNCT04846426
What this trial is testing

Amyloid Prediction in Early Stage Alzheimer's Disease From Acoustic and Linguistic Patterns of Speech - FUTURE Extension

Who this might be right for
Alzheimer DiseasePreclinical Alzheimer's DiseaseProdromal Alzheimer's Disease+2 more
Novoic Limited 67
Testing effectiveness (Phase 2)WithdrawnNCT05986721
What this trial is testing

Clinical Trial of AGB101 for Mild Cognitive Impairment

Who this might be right for
Mild Cognitive ImpairmentProdromal Alzheimer's Disease
AgeneBio
Not applicableStudy completedNCT04265378
What this trial is testing

Cognitive Training and Brain Stimulation in Prodromal Alzheimer's Disease

Who this might be right for
Subjective Cognitive DeclineMild Cognitive Impairment
University Medicine Greifswald 46
Not applicableStudy completedNCT01880151
What this trial is testing

Neuroelectrical Biomarkers for Alzheimer's Disease Stages

Who this might be right for
Alzheimer Disease
Institut National de la Santé Et de la Recherche Médicale, France 87
Not applicableEnded earlyNCT04294888
What this trial is testing

TMS in Preclinical and Prodromal AD: Modulation of Brain Networks and Memory

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentAging
Massachusetts General Hospital 4
Testing effectiveness (Phase 2)Looking for participantsNCT04804241
What this trial is testing

Senicapoc in Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
University of California, Davis 55
Large-scale testing (Phase 3)Study completedNCT01224106
What this trial is testing

Gantenerumab in Participants With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 799
Large-scale testing (Phase 3)Ended earlyNCT03444870
What this trial is testing

Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 1,053
Large-scale testing (Phase 3)Ended earlyNCT02670083
What this trial is testing

A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 813
Not applicableUnknownNCT06105320
What this trial is testing

COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study

Who this might be right for
Prodromal Alzheimer's DiseaseAlzheimer DiseaseMild Cognitive Impairment+1 more
Karolinska University Hospital 40
Not applicableLooking for participantsNCT06956300
What this trial is testing

TMS for Cognitive Decline in Aging and Preclinical AD

Who this might be right for
Prodromal Alzheimer's DiseasePreclinical Alzheimer's DiseaseHealthy Aging+1 more
Massachusetts General Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT05462106
What this trial is testing

Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Who this might be right for
Amyloid PlaqueBeta-AmyloidDSAD+2 more
AC Immune SA 304
Early research (Phase 1)Ended earlyNCT01677572
What this trial is testing

Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 197
Not applicableStudy completedNCT06033066
What this trial is testing

Financial Incentives and Recruitment to the APT Webstudy

Who this might be right for
Alzheimer DiseaseDementiaPreclinical Alzheimer's Disease+1 more
University of Southern California 44,844
Large-scale testing (Phase 3)Study completedNCT02547818
What this trial is testing

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AZTherapies, Inc. 620
Not applicableStudy completedNCT05309577
What this trial is testing

Self-Care for Dementia Caregivers

Who this might be right for
AgingMental DisorderEating, Healthy+6 more
University of Pittsburgh 21
Testing effectiveness (Phase 2)Ended earlyNCT00890890
What this trial is testing

A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 263
Testing effectiveness (Phase 2)Ended earlyNCT04592341
What this trial is testing

Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 192
Next Page